Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

University of Illinois at Chicago29 enrolled

Overview

This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility. Women wishing to preserve their oocytes using cryopreservation will be informed of the risk and limitations of the procedures involved in ovarian hyperstimulation, oocyte recovery, cryopreservation and subsequent viability after warming. Women who consent to the procedure will undergo standard controlled ovarian hyperstimulation (COH) and oocyte retrieval procedures currently in use for IVF. Following harvest all eggs obtained will be evaluated for degree of fragmentation and maturation status. The oocytes will be cryopreserved using kits of media and devices currently approved for use in the vitrification of fertilized eggs and embryos, and the cryopreserved oocytes will be stored for future patient use in a long term storage facility in Minnesota (Reprotech Ltd.). Patients with stored oocytes will be contacted annually to determine the outcome of any oocyte warming procedures (oocyte thawing, fertilization and embryo transfer). We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare medical (cancer) patients to those patients undergoing oocyte cryopreservation for non-medical reasons

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Infertility, Female Deferred Childbearing

Interventions

Investigational Oocyte CryopreservationPROCEDURE

Transvaginal oocyte retrieval under ultrasound guidance

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women aged \>18 and \< 40years * Women able to defer definitive cancer therapy for 21 to 30 days * Women diagnosed with cancer or any disease whose treatment or its progression may impair their reproductive potential (this would include but not be limited to cancer patients requiring treatment with chemotherapy or radiation, patients with rheumatologic diseases such as lupus, rheumatoid arthritis and ulcerative colitis and patients with genetic predisposition to cancers * Women undergoing standard In Vitro Fertilization to treat infertility who experience unforeseen events that halts the treatment cycle * Women seeking oocyte cryopreservation for non medical reasons, such as deferred childbearing * Women who are carriers of BRCA mutations predisposing them to cancer * Otherwise healthy females * Ability and willingness to comply with study protocol * Informed written consent, prior to any study-related procedure not part of normal care, with the understanding that the subject may withdraw consent at any time without prejudice to their future medical care Exclusion Criteria: * Current pregnancy * Serum FSH \> 10 mIU/ml for patients having egg freezing for a medical indication * Serum FSH \> 10 mIU/ml for patients having egg freezing for social reasons * Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent (Post Traumatic Stress Disorder, severe depression, bipolar disorder, schizophrenia, severe anxiety and inability to cope) * Patients with extensive disease whose therapy is deemed palliative by the medical oncologist

Locations (1)

University of Illinois Hospital & Health Sciences System - IVF Program in the Fertility Center

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare cancer patients to those patients undergoing oocyte cryopreservation for non-medical reasons. FertiQol is scored based on the standards of the assessment tool in a quantitative manner. Only 9 patients completed the this questionnaire. FertiQoL consists of 36 items that assess core (24 items) and treatment-related (10 items) quality of life as well as overall life and physical health (2 items). Higher scores indicated better outcomes and lower scores indicated worse outcomes on this questionnaire.

Time frame: Fertility quality of life questionnaire completed after one year after oocyte cryopreservation

Structured Clinical Interview Completed After One Year After Oocyte Cryopreservation for Non-medical Reasons

Study participants will be contacted on an annual basis using the "Investigational Oocyte Cropreservation Follow-up Call Script/structured interview" to determine any subsequent attempts to utilize the stored oocytes for the purpose of initiating a pregnancy, along with the outcome of the attempt. Only 9 patients completed this interview. There was not score assigned to this interview.

Time frame: structured clinical interview completed after one year after oocyte cryopreservation

Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for Cancer Patients

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare cancer patients to those patients undergoing oocyte cryopreservation for non-medical reasons. FertiQol is scored based on the standards of the assessment tool in a quantitative manner. only one cancer patient completed this questionnaire.FertiQoL consists of 36 items that assess core (24 items) and treatment-related (10 items) quality of life as well as overall life and physical health (2 items). Higher scores indicated better outcomes and lower scores indicated worse outcomes on this questionnaire.

Time frame: Fertility Quality of Life Questionnaire Completed After One Year After Oocyte Cryopreservation for cancer patients

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.